252 related articles for article (PubMed ID: 22643837)
1. Functional characterization of the human α-cardiac actin mutations Y166C and M305L involved in hypertrophic cardiomyopathy.
Müller M; Mazur AJ; Behrmann E; Diensthuber RP; Radke MB; Qu Z; Littwitz C; Raunser S; Schoenenberger CA; Manstein DJ; Mannherz HG
Cell Mol Life Sci; 2012 Oct; 69(20):3457-79. PubMed ID: 22643837
[TBL] [Abstract][Full Text] [Related]
2. Point mutations in human beta cardiac myosin heavy chain have differential effects on sarcomeric structure and assembly: an ATP binding site change disrupts both thick and thin filaments, whereas hypertrophic cardiomyopathy mutations display normal assembly.
Becker KD; Gottshall KR; Hickey R; Perriard JC; Chien KR
J Cell Biol; 1997 Apr; 137(1):131-40. PubMed ID: 9105042
[TBL] [Abstract][Full Text] [Related]
3. Using baculovirus/insect cell expressed recombinant actin to study the molecular pathogenesis of HCM caused by actin mutation A331P.
Bai F; Caster HM; Rubenstein PA; Dawson JF; Kawai M
J Mol Cell Cardiol; 2014 Sep; 74():64-75. PubMed ID: 24793351
[TBL] [Abstract][Full Text] [Related]
4. Functional Characterization of Cardiac Actin Mutants Causing Hypertrophic (p.A295S) and Dilated Cardiomyopathy (p.R312H and p.E361G).
Hassoun R; Erdmann C; Schmitt S; Fujita-Becker S; Mügge A; Schröder RR; Geyer M; Borbor M; Jaquet K; Hamdani N; Mannherz HG
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457283
[TBL] [Abstract][Full Text] [Related]
5. Human actin mutations associated with hypertrophic and dilated cardiomyopathies demonstrate distinct thin filament regulatory properties in vitro.
Debold EP; Saber W; Cheema Y; Bookwalter CS; Trybus KM; Warshaw DM; Vanburen P
J Mol Cell Cardiol; 2010 Feb; 48(2):286-92. PubMed ID: 19799913
[TBL] [Abstract][Full Text] [Related]
6. Altered interactions between cardiac myosin binding protein-C and α-cardiac actin variants associated with cardiomyopathies.
Chow ML; Shaffer JF; Harris SP; Dawson JF
Arch Biochem Biophys; 2014 May; 550-551():28-32. PubMed ID: 24736382
[TBL] [Abstract][Full Text] [Related]
7. The immediate effect of HCM causing actin mutants E99K and A230V on actin-Tm-myosin interaction in thin-filament reconstituted myocardium.
Bai F; Caster HM; Dawson JF; Kawai M
J Mol Cell Cardiol; 2015 Feb; 79():123-32. PubMed ID: 25451174
[TBL] [Abstract][Full Text] [Related]
8. Integration of Cardiac Actin Mutants Causing Hypertrophic (p.A295S) and Dilated Cardiomyopathy (p.R312H and p.E361G) into Cellular Structures.
Erdmann C; Hassoun R; Schmitt S; Kikuti C; Houdusse A; Mazur AJ; Mügge A; Hamdani N; Geyer M; Jaquet K; Mannherz HG
Antioxidants (Basel); 2021 Jul; 10(7):. PubMed ID: 34356314
[TBL] [Abstract][Full Text] [Related]
9. Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
Robinson P; Griffiths PJ; Watkins H; Redwood CS
Circ Res; 2007 Dec; 101(12):1266-73. PubMed ID: 17932326
[TBL] [Abstract][Full Text] [Related]
10. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes.
Flavigny J; Souchet M; Sébillon P; Berrebi-Bertrand I; Hainque B; Mallet A; Bril A; Schwartz K; Carrier L
J Mol Biol; 1999 Nov; 294(2):443-56. PubMed ID: 10610770
[TBL] [Abstract][Full Text] [Related]
11. M-class hypertrophic cardiomyopathy cardiac actin mutations increase calcium sensitivity of regulated thin filaments.
Teng GZ; Shaikh Z; Liu H; Dawson JF
Biochem Biophys Res Commun; 2019 Oct; 519(1):148-152. PubMed ID: 31481237
[TBL] [Abstract][Full Text] [Related]
12. Vascular disease-causing mutation R258C in ACTA2 disrupts actin dynamics and interaction with myosin.
Lu H; Fagnant PM; Bookwalter CS; Joel P; Trybus KM
Proc Natl Acad Sci U S A; 2015 Aug; 112(31):E4168-77. PubMed ID: 26153420
[TBL] [Abstract][Full Text] [Related]
13. [Abnormal tropomyosin function in ATPase cycle in hypertrophic and dilated cardiomyopathies].
Borovikov IuS; Karpicheva OE; Rysev NA; Redwood CS
Ross Fiziol Zh Im I M Sechenova; 2013 Jan; 99(1):73-80. PubMed ID: 23659058
[TBL] [Abstract][Full Text] [Related]
14. Cardiac actin changes in the actomyosin interface have different effects on myosin duty ratio.
Liu H; Henein M; Anillo M; Dawson JF
Biochem Cell Biol; 2018 Feb; 96(1):26-31. PubMed ID: 28972856
[TBL] [Abstract][Full Text] [Related]
15. Investigation of a truncated cardiac troponin T that causes familial hypertrophic cardiomyopathy: Ca(2+) regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein.
Redwood C; Lohmann K; Bing W; Esposito GM; Elliott K; Abdulrazzak H; Knott A; Purcell I; Marston S; Watkins H
Circ Res; 2000 Jun; 86(11):1146-52. PubMed ID: 10850966
[TBL] [Abstract][Full Text] [Related]
16. Hypertrophic cardiomyopathy-linked variants of cardiac myosin-binding protein C3 display altered molecular properties and actin interaction.
Da'as SI; Fakhro K; Thanassoulas A; Krishnamoorthy N; Saleh A; Calver BL; Safieh-Garabedian B; Toft E; Nounesis G; Lai FA; Nomikos M
Biochem J; 2018 Dec; 475(24):3933-3948. PubMed ID: 30446606
[TBL] [Abstract][Full Text] [Related]
17. De Novo Asp219Val Mutation in Cardiac Tropomyosin Associated with Hypertrophic Cardiomyopathy.
Tsaturyan AK; Zaklyazminskaya EV; Polyak ME; Kopylova GV; Shchepkin DV; Kochurova AM; Gonchar AD; Kleymenov SY; Koubasova NA; Bershitsky SY; Matyushenko AM; Levitsky DI
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613463
[TBL] [Abstract][Full Text] [Related]
18. Properties of Cardiac Myosin with Cardiomyopathic Mutations in Essential Light Chains.
Yampolskaya DS; Kopylova GV; Shchepkin DV; Bershitsky SY; Matyushenko AM; Levitsky DI
Biochemistry (Mosc); 2022 Nov; 87(11):1260-1267. PubMed ID: 36509720
[TBL] [Abstract][Full Text] [Related]
19. A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunction.
Kuster DW; Govindan S; Springer TI; Martin JL; Finley NL; Sadayappan S
J Biol Chem; 2015 Feb; 290(9):5855-67. PubMed ID: 25583989
[TBL] [Abstract][Full Text] [Related]
20. Hypertrophic cardiomyopathy mutations in the calponin-homology domain of ACTN2 affect actin binding and cardiomyocyte Z-disc incorporation.
Haywood NJ; Wolny M; Rogers B; Trinh CH; Shuping Y; Edwards TA; Peckham M
Biochem J; 2016 Aug; 473(16):2485-93. PubMed ID: 27287556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
